Related by context. All words. (Click for frequent words.) 73 immune thrombocytopenic purpura 72 idiopathic thrombocytopenic purpura ITP 70 HeFH 69 hepatorenal syndrome 69 non splenectomized 69 recurrent glioblastoma multiforme 68 metastatic malignant 68 invasive candidiasis 68 idiopathic thrombocytopenic purpura 68 eosinophilic asthma 68 interstitial pneumonia 68 Acute Myeloid Leukaemia AML 68 Infusion Reactions Severe 68 leukemia AML 68 Myelodysplastic Syndrome MDS 67 hemorrhagic cystitis 67 exocrine pancreatic insufficiency EPI 67 diabetic gastroparesis 67 active ankylosing spondylitis 67 severe malignant osteopetrosis 67 haematologic 67 relapsed MM 67 chronic idiopathic thrombocytopenic purpura 67 Cimzia TM 67 acute mania 66 patientswith 66 chronic GVHD 66 thetreatment 66 receiving XGEVA 66 ANCA associated 66 Glioblastoma Multiforme 66 Ribavirin causes 66 antibody MAb 66 Clinically significant 66 esophageal candidiasis 66 bullous 66 oropharyngeal candidiasis OPC 66 neutropenia dehydration dyspnea 66 Major Depressive Disorder MDD 66 primary immunodeficiency PI 66 vWD 66 oxypurinol 66 FluCAM arm 66 rheumatoid arthritis psoriatic arthritis 66 overactive bladder syndrome 65 pulmonary hypertension PH 65 refractory anaplastic astrocytoma 65 chronic renal insufficiency 65 sJIA 65 multiple myeloma MM 65 relapsed leukemia 65 anagrelide 65 Amgen Neulasta R 65 heparin induced thrombocytopenia 65 invasive aspergillosis 65 anemia neutropenia 65 alpha1 antitrypsin deficiency 65 chronic granulomatous disease 65 candidemia 65 proliferative retinopathy 65 Amgen Neulasta ® 65 severe oral mucositis 65 malignant ascites 65 GH deficiency 65 acute GvHD 65 Chronic Myelogenous Leukemia CML 65 deep venous thromboses 65 Cimzia ® certolizumab pegol 65 thrombotic thrombocytopenic purpura 65 retinal vein occlusion induced 65 Angioedema 65 chronic immune thrombocytopenic 65 steroid refractory GvHD 65 complement inhibitor eculizumab 65 VFEND 65 CLL SLL 65 pemphigus vulgaris 65 pancytopenia 65 leukoencephalopathy 65 recurrent DVT 65 polyarticular 65 Toxicities 65 non metastatic osteosarcoma 65 smoldering myeloma 65 debilitating complication 65 decompensated liver disease 64 post herpetic neuralgia PHN 64 MELAS 64 psoriatic arthritis PsA 64 chronic thromboembolic pulmonary 64 primary IGFD 64 immunocompetent patients 64 chronic rheumatic 64 ankylosing spondylitis AS 64 acetonide FA 64 CTEPH 64 post transplant lymphoproliferative 64 interferon ribavirin 64 juvenile idiopathic arthritis 64 smoldering multiple myeloma 64 benign prostatic hypertrophy BPH 64 hematologic disorders 64 TNF antagonist 64 severe hypersensitivity reactions 64 biliary tract cancer 64 leukemia ALL 64 hypereosinophilic syndrome 64 allograft rejection 64 pouchitis 64 alemtuzumab treated 64 symptomatic intracranial 64 neovascularisation 64 decompensated heart failure 64 rheumatoid arthritis osteoarthritis ankylosing 64 myeloid metaplasia 64 pericardial effusion 64 prospectively enrolled 64 Dermatologic toxicities 64 adalimumab Humira 64 immunomodulatory therapy 64 pancreatic insufficiency 64 Helicobacter pylori eradication 64 hyperphenylalaninemia HPA due 64 hyperammonemia 64 Crohns disease 64 mycosis fungoides 64 TASKi3 64 Acute Coronary Syndromes ACS 64 neutropenic sepsis 64 hepatic encephalopathy HE 64 lymphocytic leukemia 64 failure ADHF 64 Dacogen decitabine 64 riociguat 64 posterior uveitis 64 homozygous familial hypercholesterolemia 64 mitoxantrone plus 64 argatroban 64 Alequel 64 purpura ITP 64 SPRYCEL ® 64 mild renal insufficiency 64 chronic myeloid 64 basiliximab 64 diabetic kidney 64 Rheumatoid Arthritis RA 64 SJIA 64 herpes zoster shingles 64 Abrupt discontinuation 63 vasospasm 63 Hypotension 63 symptomatic paroxysmal AF 63 neovascular diseases 63 pheochromocytoma 63 Lupus nephritis 63 Noxafil 63 refractory gout 63 myeloproliferative disorder 63 atypical hemolytic uremic syndrome 63 gastrointestinal toxicities 63 demyelinating 63 lupus nephritis 63 EXJADE 63 NATRECOR ® 63 Tarceva TM 63 MCyR 63 erythema nodosum 63 calcineurin inhibitor 63 Venous thromboembolism 63 Chronic Prostatitis 63 Severe Primary IGFD 63 pediatric Crohn disease 63 neurological manifestations 63 acute myeloid 63 rFVIIa 63 phase IIb study 63 cutaneous lupus 63 Vidaza azacitidine 63 Gleevec resistant 63 secondary hyperparathyroidism 63 Acute myeloid leukemia 63 cystic fibrosis chronic pancreatitis 63 metastatic malignant melanoma 63 genitourinary GU 63 variceal bleeding 63 constipation OIC 63 induce orthostatic hypotension 63 chronic HCV infection 63 HBeAg negative 63 either acutely decompensated 63 dexanabinol 63 salmeterol fluticasone 63 interstitial pneumonitis 63 recurrent glioblastoma 63 glucocorticoid induced osteoporosis 63 neurogenic bladder 63 PAOD 63 recurrent herpes labialis 63 Eisenmenger syndrome 63 anthracyclines taxanes 63 exocrine pancreatic insufficiency 63 polycythemia vera essential thrombocythemia 63 multisystem organ failure 63 MGd 63 visilizumab 63 Dacogen injection 63 somatostatin analog 63 generalized tonic clonic seizures 63 severe neutropenia 63 anthracycline taxane 63 baminercept 63 haematological cancers 63 refractory myeloma 63 intracranial hemorrhage ICH 63 relapsing remitting MS RRMS 63 corticosteroids immunoglobulins 63 Fingolimod 63 Idiopathic Pulmonary Fibrosis 63 CHOP chemotherapy 63 COPD exacerbation 63 PCNSL 63 idiopathic pulmonary fibrosis IPF 63 tuberous sclerosis TS 63 anterior uveitis 63 denileukin diftitox 63 retinal vein occlusion 63 thrombotic complications 63 myelogenous leukemia 63 forodesine 63 recurrent glioblastoma multiforme GBM 63 Myelodysplastic Syndrome 63 benign prostatic hypertrophy 63 aflibercept VEGF Trap 63 gastrointestinal stromal tumors GIST 63 BARACLUDE ® 63 dermatologic reactions 63 transthyretin amyloidosis 63 medically refractory 63 pegylated alpha interferon 63 EFFEXOR XR 63 venous stasis ulcers 63 paroxysmal nocturnal hemoglobinuria PNH 63 chronic eosinophilic leukemia 63 antiretroviral naïve 63 sensory neuropathy 63 tumor lysis syndrome 62 diffuse intrinsic pontine glioma 62 budesonide foam 62 late onset Pompe 62 ribavirin therapy 62 Certolizumab pegol 62 autoantibody positive 62 recurrent genital herpes 62 hypercholesterolaemia 62 arterial thrombosis 62 invasive fungal infection 62 gastroduodenal 62 Systemic Lupus Erythematosus SLE 62 cilengitide 62 choroidal vasculopathy 62 febrile neutropenia 62 dysmotility 62 nosocomial pneumonia 62 myocardial infarction ventricular fibrillation 62 G CSFs 62 enterocolitis 62 OHR/AVR# 62 metastatic uveal melanoma 62 congenital fibrinogen deficiency 62 commercialize deforolimus 62 sitaxsentan 62 renal scarring 62 CytoFab ™ 62 idiopathic Parkinson disease 62 CIMZIA TM 62 Thrombocytopenia 62 Juvenile Idiopathic Arthritis 62 headache abdominal pain 62 Retreatment 62 crohn disease 62 hepatic encephalopathy 62 arteritis 62 clazosentan 62 myelofibrosis bone marrow 62 de novo AML 62 unresectable stage 62 pediatric bipolar disorder 62 neutropenia febrile neutropenia 62 Biaxin R 62 hypophosphatemia 62 neovascular 62 delayed CINV 62 steroid refractory ulcerative 62 FRAGMIN 62 diabetic peripheral neuropathy DPN 62 mCRC acneform rash 62 peritumoral brain edema 62 severe exacerbations 62 Heterozygous Familial Hypercholesterolemia 62 Kit CD# positive 62 Staphylococcus aureus infections 62 hypercalcemia 62 infective endocarditis 62 CIMZIA TM certolizumab pegol 62 PTLD 62 Zarnestra 62 relapsed CLL 62 idiopathic PAH 62 biologic DMARD 62 myelodysplastic myeloproliferative diseases 62 treatment naive genotype 62 herpetic keratitis 62 rhIGF-I/rhIGFBP-3 62 Intravenous immunoglobulin 62 reduce serum phosphate 62 rebleeding 62 myeloproliferative diseases 62 Pelvic Inflammatory Disease 62 gastrointestinal perforation 62 refractory Hodgkin 62 diabetic retinopathy DR 62 ALT flares 62 Friedreich Ataxia FRDA 62 Glioblastoma Multiforme GBM 62 hematologic toxicity 62 dopaminergic therapy 62 Chronic Myeloid Leukemia 62 constipation predominant irritable bowel 62 cisplatin chemotherapy 62 KRAS mutations occur 62 predominantly classic subfoveal 62 recurrent metastatic 62 hemoptysis 62 bacterial prostatitis 62 8mg/kg 62 SNT-MC#/idebenone 62 heterozygous FH 62 kidney urologic 62 congenital deficiency 62 SSc 62 refractory NSCLC 62 de novo kidney transplant 62 CML CP 62 paroxysmal atrial fibrillation 62 Aggrastat ® tirofiban hydrochloride 62 adverse cytogenetics 62 coagulation disorders 62 pulmonary artery hypertension 62 metastatic bladder 62 Carbaglu 62 localized renal 62 Idiopathic Pulmonary Fibrosis IPF 62 squamous cell lung cancer 62 gastrointestinal reflux 62 null responder 62 Kinoid 62 onset seizures 62 NAGS deficiency 62 rufinamide 62 syncope fainting 62 ARCOXIA 62 lumbar spinal stenosis LSS 62 atopic dermatitis AD 62 myeloproliferative disorders 62 intracerebral hemorrhage ICH 62 etanercept Enbrel 62 cerebral vasospasm 62 type 1diabetes 62 von Willebrand disease 62 ara C 62 Natalizumab 62 PROCRIT ® 62 chronic urticaria 62 primary Restless Legs 62 lupus erythematosus 62 Waldenstrom macroglobulinemia 62 Ankylosing spondylitis 62 ADPKD 62 Pegylated Interferon 62 proliferative diabetic retinopathy 62 uremic pruritus 62 antiphospholipid syndrome 62 rituximab refractory 62 artery stenosis 62 opioid induced bowel dysfunction 62 induce remission 62 Zavesca ® 62 carcinoid syndrome 62 partial onset seizures 62 ZOLINZA 62 immunodeficiency disorders 62 Acute Bacterial Sinusitis ABS 62 treatmentof 62 recurrent malignant glioma 62 chemotherapy induced thrombocytopenia 62 golimumab CNTO 62 AGILECT R 62 neutropenic fever 62 MULTAQ 62 gastrointestinal stromal tumor GIST 62 metastatic neuroendocrine tumors 62 Immune Thrombocytopenic Purpura 62 ICD shocks 62 nucleotide analog 62 unruptured aneurysm 62 TMS Therapy 62 vidofludimus 61 Veno Occlusive Disease 61 HER2 overexpression 61 NSAID induced 61 Abilify aripiprazole 61 antiretroviral naive 61 ZACTIMA 61 papillary renal cell carcinoma 61 aHUS 61 CYT# potent vascular disrupting 61 osteoporotic vertebral compression fractures 61 catheter occlusion 61 atypical Hemolytic Uremic Syndrome 61 advanced medullary thyroid 61 progressive PsA 61 divalproex sodium 61 Acute Myelogenous Leukemia AML 61 advanced hepatocellular carcinoma 61 4mg/kg 61 unstable angina UA 61 RSD# oral 61 Janus Kinase 61 retinal vein occlusion RVO 61 toenail onychomycosis 61 Navelbine ® 61 refractory CLL 61 Febrile neutropenia 61 IV NSCLC 61 thrombophlebitis 61 psoriasis vulgaris 61 alpha1 antitrypsin AAT deficiency 61 Seroquel quetiapine fumarate 61 hepatitis C genotype 61 Renal impairment 61 venous thromboembolic disease 61 Hodgkin lymphoma HL 61 prokinetic agent 61 cytopenias 61 depression TRD 61 lumiliximab 61 elevated transaminases 61 leucopenia 61 lintuzumab SGN 61 TTR amyloidosis 61 RezularTM 61 receptor tyrosine kinase inhibitor 61 follicular Non Hodgkin 61 Myelofibrosis 61 efalizumab 61 metastatic GIST 61 refractory acute myeloid 61 diabetic neuropathic pain 61 dyslipidemia hypertension diabetes 61 severe Primary IGFD 61 Critical Limb Ischemia CLI 61 prescribed proton pump 61 Bronchiectasis 61 Raynaud syndrome 61 causative pathogen 61 ORENCIA ® 61 grade cervical intraepithelial 61 Gastrointestinal GI 61 AA Amyloidosis 61 underwent resection 61 corticosteroid dexamethasone 61 Pulmonary Arterial Hypertension PAH 61 glucocorticoid therapy 61 antithrombotic therapy 61 systemic JIA 61 CIMZIA ™ 61 postoperative atrial fibrillation 61 pulmonary infiltrates 61 Genentech Rituxan 61 Pharmacokinetics PK 61 hour bronchodilation 61 HIV HCV coinfected 61 KETEK 61 systemic corticosteroid 61 adult chronic ITP 61 painful diabetic neuropathy 61 R abatacept 61 CAELYX 61 hypocalcemia 61 neurogenic orthostatic hypotension 61 thrombocytopenic 61 duodenal ulcer 61 Lactic acidosis 61 methimazole 61 overt nephropathy 61 diabetes mellitus DM 61 INS# [001] 61 colorectal cancer liver metastases 61 levodopa induced 61 phase IIb trial 61 metastatic carcinoid tumors 61 subependymal giant cell 61 sargramostim 61 DPNP 61 relapsed ALL 61 symptomatic VTE 61 neonatal jaundice 61 cancer neuroendocrine tumor 61 thromboembolic disease 61 Pemetrexed 61 opioid induced constipation OIC 61 hyperlipidaemia 61 serologically active systemic lupus 61 VaD 61 ACTEMRA TM 61 Neovascular AMD 61 varicella infection 61 vapreotide acetate 61 degenerative lumbar 61 Crohn disease CD 61 eritoran 61 Plaquenil 61 selective phosphodiesterase 61 cSSSIs 61 Acute Exacerbations 61 generalized seizures 61 urolithiasis 61 TMP SMX 61 mild hepatic impairment 61 chronic ITP patients 61 #I TM# 61 superficial basal cell carcinoma 61 Xelox 61 dose escalation phase 61 hyperprolactinemia 61 CytoFabTM 61 noninfectious uveitis 61 R adalimumab 61 metastatic renal cell 61 Raptiva ® 61 juvenile idiopathic arthritis JIA 61 Gleevec imatinib 61 Soft Tissue Sarcoma 61 thromboembolic complications 61 epiglottitis 61 Behcet uveitis 61 bone marrow reticulin deposition 61 suppurative 61 HIV coinfected 61 stage IIIb 61 nonmetastatic prostate cancer 61 meropenem 61 Diamyd r 61 prolonged QT interval 61 metastatic CRC 61 pediatric acute lymphoblastic 61 moderately emetogenic 61 Raptiva efalizumab 61 Fluid retention 61 Lixivaptan 61 systemic ALCL 61 postherpetic neuralgia PHN 61 external genital lesions 61 rheumatic arthritis 61 Zavesca R 61 gastric carcinoma 61 Peginterferon alfa 2b 61 tyrosine kinase inhibitors TKIs 61 concomitant antibiotics 61 Wegener granulomatosis 61 systemic fungal infections 61 CRVO 61 renal kidney 61 intravenous vancomycin 61 unfavorable cytogenetics 61 relapsed ovarian cancer 61 fistulizing Crohn disease 61 lymphocytosis 61 decompensated cirrhosis 61 CMV infections 61 Pseudomonas aeruginosa infections 61 purpura 61 Hepatocellular Carcinoma HCC 61 weekly intravenous infusions 61 ribavirin RBV 61 myalgia arthralgia 61 ocular inflammatory 61 venlafaxine XR 61 primary humoral immunodeficiency 61 Dementia Related Psychosis 61 hemophilia B. 61 morphometric vertebral fractures 61 Polyneuropathy 61 Community Acquired Pneumonia 61 Chronic lymphocytic leukemia 61 allogeneic bone marrow 61 conventional DMARDs 61 Leber Hereditary Optic Neuropathy 61 essential thrombocythemia ET 61 minimally symptomatic 61 unstable angina pectoris 61 receiving VELCADE 61 relapsing multiple sclerosis 61 acute HAE attacks 61 Acute Myeloid Leukaemia 61 moderate renal impairment 61 PEGINTRON TM 61 Cinquil 61 Hemophilia B 61 concomitant AEDs 61 osteoarthritis rheumatoid arthritis 61 Infusion reactions 61 Relapsing Remitting Multiple Sclerosis 61 necrotizing pancreatitis 61 #mg BID [001] 61 hoFH 61 splenectomized 61 Pagoclone 61 Neovascular Age Related Macular 61 refractory AML 61 colorectal liver metastases 61 VIIBRYD 61 pseudomembranous colitis 61 C1 INH deficiency 61 Adjunctive 61 metastatic renal cell carcinoma 61 APTIVUS r 61 Degarelix 61 basal cell carcinoma BCC 61 pain palliation 61 Diffuse Large B 61 Critical Limb Ischemia 61 heFH 60 achieved CCyR 60 Evoltra TM 60 decompensated 60 reflux disease GERD 60 induced macular edema 60 treat chronic sinusitis 60 torsade de pointes 60 bleeding pallor 60 colorectal adenoma 60 systemic mastocytosis 60 briakinumab 60 atherothrombotic events 60 systemic hypotension 60 choroidal neovascularization 60 methotrexate therapy 60 hematologic abnormalities 60 lomitapide 60 diarrhea predominant irritable 60 GW# [003] 60 parkinsonian symptoms 60 autoimmune hemolytic anemia 60 refractory metastatic colorectal cancer 60 pathologic myopia 60 acute lymphoblastic 60 chronic periodontitis 60 transplantation HCT 60 receiving highly emetogenic 60 femoral neck fracture 60 receiving immunosuppressive therapy 60 INVEGA ® 60 chorea associated 60 Evoltra ® 60 clevidipine 60 discoid lupus 60 T1c 60 biochemical relapse 60 venous blood clots 60 DepoCyt 60 eosinophilic pneumonia 60 intravenous immunoglobulin 60 atrial tachyarrhythmias 60 PEG IFN 60 hylan GF 60 acute gout flares 60 miglustat 60 severe hypoglycaemia 60 acne vulgaris 60 cutaneous T 60 MPS VI 60 intravitreal insert 60 lactic acidosis 60 thrombocytopenic patients 60 MALT lymphoma 60 orchitis 60 dual endothelin receptor antagonist 60 refractory epilepsy 60 syncopal episodes 60 Pegasys plus Copegus 60 corticosteroid therapy 60 MAGE A3 ASCI 60 leukemia APL 60 Candida infection 60 fallopian tube carcinoma 60 TNF alpha inhibitor 60 acromegalic patients 60 nadolol 60 unresectable HCC 60 hypocalcaemia 60 relapsed refractory multiple myeloma 60 allogeneic HSCT 60 thrombocytopenia neutropenia 60 rheumatoid arthritis Crohn disease 60 elevated ALT 60 nonsevere 60 Firazyr 60 chronic hepatitis cirrhosis 60 mycophenolate mofetil MMF 60 gastro esophageal reflux 60 Hydroxyurea 60 metastatic bone 60 thrombotic thrombocytopenic purpura TTP 60 Kepivance 60 intravenous heparin 60 Gorlin syndrome 60 GvHD 60 gouty arthritis 60 Decitabine 60 naïve HCV 60 tipifarnib 60 nephritis 60 onset atrial fibrillation 60 tipranavir ritonavir 60 galiximab 60 blood clotting disorder 60 volociximab 60 non hodgkin lymphoma 60 hepatic insufficiency 60 malignant neoplasms 60 tumors GIST 60 intra abdominal abscess 60 interstitial nephritis 60 mastocytosis 60 mediastinitis 60 idraparinux 60 sodium stibogluconate 60 abnormal uterine bleeding 60 gastrointestinal stromal tumor 60 Host Disease GvHD 60 Isentress raltegravir 60 NMIBC 60 resectable pancreatic cancer 60 desvenlafaxine succinate 60 Xyfid TM 60 LHRH receptor positive 60 ano genital warts 60 Zenvia ™ 60 thalidomide Thalomid 60 hypervascular tumors 60 superficial bladder cancer 60 Renal Impairment 60 demonstrated antitumor activity 60 including eniluracil ADH 60 Stage IIB 60 Velcade bortezomib 60 Lymphocytic 60 Chronic ITP 60 chemotherapy induced neutropenia 60 subarachnoid hemorrhage SAH 60 rheumatoid arthritis inflammatory bowel 60 Associated Adipose Redistribution 60 FROVA 60 intravenous immunoglobulin IVIg 60 arthritis PsA 60 metastatic gastric 60 SomatoKine R 60 recurrent bladder 60 pamidronate 60 symptomatic BPH 60 ximelagatran 60 aprepitant 60 postoperative AF 60 relapsed AML 60 Fanconi syndrome 60 systemic lupus erythematosus 60 enoxaparin Lovenox 60 lenalidomide dexamethasone 60 grade cervical dysplasia 60 PsA 60 DEB# 60 canakinumab 60 Investigational Treatment 60 convulsive disorders 60 pathologic fractures 60 Primary IGFD 60 oxymorphone ER 60 methotrexate monotherapy 60 keloid scarring 60 included exfoliative dermatitis 60 Torsades de Pointes 60 ischemic complications 60 tardive dyskinesia TD 60 Bezielle 60 antiepileptic medications 60 radiotherapy RT 60 palliative radiotherapy 60 refractory metastatic 60 TNF inhibitor therapy 60 Tardive dyskinesia 60 receiving PEGINTRON 60 INSPIRE Trial Phase III 60 voiding dysfunction 60 treatment naïve genotype 60 RoACTEMRA 60 PegIFN RBV 60 Known hypersensitivity 60 coagulopathy 60 Anti VEGF 60 Motavizumab 60 intranasal formulation 60 comparator arm 60 weekly subcutaneous injections 60 cystoid macular edema 60 oral Hycamtin 60 CMV retinitis 60 EVIZON TM 60 Sclerosing 60 immune globulin intravenous 60 myeloproliferative neoplasms 60 cough dyspnea 60 refractory chronic lymphocytic 60 heavily pretreated 60 enteroviral infection 60 Lambert Eaton Myasthenic 60 hematological toxicity 60 PEGylated Fab fragment 60 obscure gastrointestinal bleeding 60 follicular lymphoma FL 60 myotonic muscular dystrophy 60 cytomegalovirus infection 60 oral vancomycin 60 systemic anaplastic large 60 OZURDEX ® 60 Dosa suffers 60 Diabetic Macular Edema DME 60 Systemic Lupus Erythematosus 60 Tumors shrank 60 HBeAg positive patients 60 pioglitazone HCl 60 chronic plaque psoriasis 60 antiplatelet medications 60 sodium thiosulfate STS 60 opioid dependent 60 Aryplase 60 Chronic myeloid leukemia 60 infantile spasms 60 neurocognitive deficits 60 acutely decompensated heart 60 Critical limb ischemia 60 Crohn disease bowel 60 refractory angina 60 ATACAND 60 lymphoid malignancies 60 Golimumab 60 LymphoStat B belimumab 60 Tasimelteon 60 achieved ACR# 60 LHRH analogues 60 INCB# [003] 60 deletion 5q 60 T1DM 60 oral thrush 60 rituximab Rituxan 60 B Cell Lymphoma 60 FOLFOX chemotherapy 60 disseminated intravascular coagulation DIC 60 congenital ichthyosis 60 generalized edema 60 mcg kg REBETOL 60 PRT# 60 Prosaptide 60 Telithromycin 60 drotrecogin alfa activated 60 romiplostim 60 comorbid depression 60 Sutent sunitinib 60 factor TNF 60 Diabetic Retinopathy DR 60 nephrotoxicity 60 superficial basal cell carcinomas 60 relapsed multiple myeloma 60 haematological toxicity 60 humanised monoclonal antibody 60 macular edema secondary 60 PEGylated interferon beta 1a 60 recessive dystrophic epidermolysis bullosa 60 psoriasis psoriatic arthritis 60 virologic breakthrough 60 bendamustine 60 Lennox Gastaut syndrome 60 MabThera Rituxan 60 terlipressin 60 lichen planus 60 metastatic renal 60 hepatic toxicity 60 AMEVIVE 60 indolent NHL 60 interferon gamma 1b 60 Adjuvant chemotherapy 60 angioneurotic edema 60 Fx #A 60 hereditary antithrombin deficiency 60 AGHD 60 subcutaneous immunoglobulin 60 Omacetaxine 60 cutaneous squamous cell carcinoma 60 chemo radiotherapy 60 gallium nitrate 60 erythropoietic 60 relapsing remitting 60 gastrointestinal mucositis 60 stable angina pectoris 60 intravenous cyclophosphamide 60 thalassemia sickle cell 60 subcutaneous methylnaltrexone 60 prospective multicenter study 60 steroid refractory 60 dyskeratosis congenita 60 C. difficile diarrhea 60 antirheumatic 60 Enzyme Replacement Therapy 60 intravenous bisphosphonates 60 underwent liver transplantation 60 bowel resection 60 Zollinger Ellison syndrome 60 quetiapine fumarate 60 ulcerative colitis UC 60 vaso occlusive crisis 60 Progressive Multifocal Leukoencephalopathy PML 60 TNF antagonist therapy 60 thrombocytosis 60 FOLFOX6 60 visceral metastases 60 Navelbine R 60 pulmonary thromboembolism 60 clinically asymptomatic 60 autoimmune thyroiditis 60 mania hypomania 60 generation purine nucleoside 60 deferiprone 60 Mg Usa 60 myeloproliferative disease 60 interferon alpha IFN 60 Glypromate 60 acyclovir Lauriad R 60 hemodynamically stable 60 FSAD 59 paroxysmal nocturnal hemoglobinuria 59 Sezary syndrome 59 investigational monoclonal antibody 59 Troxatyl 59 Gleevec Glivec 59 ELACYT 59 neurocognitive impairment 59 cholestasis 59 pharyngitis tonsillitis 59 metastatic colorectal carcinoma 59 Diabetic Neuropathy 59 verteporfin 59 SNT MC# 59 VAPRISOL 59 bortezomib refractory 59 mucosal inflammation 59 octreotide LAR 59 MPGN 59 subarachnoid haemorrhage 59 miconazole Lauriad ® 59 lenalidomide Revlimid R 59 somatostatin analogues 59 Aviptadil 59 cognitive impairment associated 59 antiarrhythmic drug 59 G#DT 59 certolizumab 59 severe hepatic dysfunction 59 recurrent venous thromboembolism 59 Fludarabine 59 estramustine 59 membranous nephropathy 59 Follicular Lymphoma 59 GISTs 59 Teriflunomide 59 variceal hemorrhage 59 rheumatologic 59 pediatric malignancies 59 tegaserod 59 veno occlusive disease 59 Leber congenital amaurosis LCA 59 HBV infections 59 CP CPPS 59 beta 1a 59 Relapsing remitting MS 59 cervical degenerative disc 59 nicardipine 59 precancerous condition 59 Gamunex C 59 anthracycline containing